loader

chief medical officer

LATEST ARTICLES
pharmaceutical investing

FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary

Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical Trial

pharmaceutical investing

Adamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI

BeiGene Presents Clinical Data on Pamiparib in Chinese Patients with Ovarian Cancers or Triple-Negative Breast Cancer

BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Relapsed or Refractory Mature T-and NK-Cell Lymphomas

pharmaceutical investing

Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation to Expand the Clinical Research on IMO-2125

G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer

pharmaceutical investing

Reata Provides Update on the Phase 2 Portion of the CARDINAL Study of Bardoxolone Methyl in Patients With Alport Syndrome

pharmaceutical investing

Zynerba Pharmaceuticals Initiates Open-Label Phase 2 Trial of ZYN002 in Developmental and Epileptic Encephalopathies

BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Previously Treated Hepatocellular Carcinoma

pharmaceutical investing

Data Monitoring Committee Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study

pharmaceutical investing

Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES